Metys Pharmaceuticals

Metys Pharmaceuticals

Pharmaceutical Manufacturing Basel, Basel-stadt, Ch 2 employees
Employees
2
Contacts
1
Emails
1

Metys Pharmaceuticals Overview

Headquarters
Basel, Basel-stadt, Ch
Phone Number
Available in AeroLeads
Website
metys-pharma.ch
Industry
Pharmaceutical Manufacturing
Employees
2
Founded
2013
Funding
81.9K
Company Email
Available in AeroLeads
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
Keywords

About Metys Pharmaceuticals

Metys Pharmaceuticals is developing dimiracetam for the prevention of chemotherapy-induced painful peripheral neuropathy. In the US alone, in a single year, more than 400'000 patients suffer from the neuropathy caused by their life-saving cancer treatment. No drug has been approved to prevent or treat this condition. Dimiracetam is an orally active, small molecule with more than 200 patients' safety and tolerability data; dimiracetam is highly effective in preventing and treating chemotherapy-induced neuropathy in rodents. Metys Pharmaceuticals is preparing the first dedicated efficacy study of dimiracetam in this indication.

Metys Pharmaceuticals Contact Details

People in AeroLeads
1
With contact data
1
Email contacts
1
100.0% coverage

Metys Pharmaceuticals Org Chart

Sample employees and titles
Name Title Contact
Michael Scherz Pharmaceutical R&D Project Leader
Email

Compare Similar Companies to Metys Pharmaceuticals